A case of fraud in a neurological pharmaceutical clinical trial;Een geval van fraude bij farmaceutisch onderzoek in de neurologie

Nederlands Tijdschrift voor Geneeskunde

Volumn 147, Issue 28, 2003, Pages 1372-1377

  Hoeksema, H L ^a   Troost, J ^e   Grobbee, D E ^b   Wiersinga, W M ^c   Van Wijmen, F C B ^b   Klasen, E C ^d  

^a ZonMw The Netherlands Organisation for Health Research and Development   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FORGERY; GENERAL PRACTITIONER; HUMAN; LAW; LEGAL ASPECT; MEDICAL ETHICS; MEDICAL RESEARCH; NETHERLANDS; ORGANIZATION; PRISON; PROPHYLAXIS; QUESTIONNAIRE;

CLINICAL TRIALS; ETHICS COMMITTEES; ETHICS, RESEARCH; HUMANS; NETHERLANDS; NEUROLOGY; SCIENTIFIC MISCONDUCT;

EID: 0038168166     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Lock S, Wells F, editors. Fraud and misconduct in medical research. Londen: British Medical Journal Publishing Group; 1996.
2. Evered D, Lazar P. Misconduct in medical research. Lancet 1995;345:1161-2.
3. Abbott A. Researcher sues over 'fraud' sanction. Nature 1997;390:652.
4. Dyer C. Doctor admits research fraud. BMJ 1998;316:647.
5. Kennedy D. More questions about research misconduct. Science 2002;297:13.
6. Brumfiel G. Misconduct finding at Bell Labs shakes physics community. Nature 2002;419:419-21.
7. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13.
8. Enserink M. Fraud and ethics charges hit stroke drug trial. Science 1996;274:2004-5.
9. Leenen HJJ. Handboek gezondheidsrecht. Deel I. Rechten van mensen in de gezondheidszorg. 3e dr. Alphen aan den Rijn: Samson Tjeenk Willink; 1994.
10. Good clinical practice, internationaal richtsnoer voor het onderzoek met geneesmiddelen. Utrecht: Nefarma; 1998.
11. Ganten D. Worse than pulp fiction: fraud in science. J Mol Med 1997;75:689-91.
12. Hoeksema HL, Troost J, Grobbee DE, Wiersinga WM, Wijmen FCB van, Klasen EC. Fraud in a pharmaceutical trial. Lancet 2000;356:1773.
13. Crul BVM, Rijksen MP. Fraude in geneesmiddelentrial. Med Contact 2001;56:1745.
14. Neuroloog krijgt boete. NRC Handelsblad 17 september 2002.
15. Klasen EC, Overbeke AJPM. Melding van wetenschappelijk wangedrag in gezondheidsonderzoek. Ned Tijdschr Geneeskd 2002;146:1622-4.
16. Vermeulen M. Researchcode in het Academisch Medisch Centrum te Amsterdam: nuttig. Ned Tijdschr Geneeskd 2002;146:1620-2.
17. Maassen H. Firma List en Bedrog. Med Contact 2002;57:356-9.
18. Nylenna M, Andersen D, Dahlquist G, Sarvas M, Aakvaag A. Handling of scientific dishonesty in the Nordic countries. National Committees on Scientific Dishonesty in the Nordic Countries. Lancet 1999;354:57-61.